Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia

Ing Soo Tiong, Peter Tan, Julie McManus, Nik Cummings, Sonali Sadawarte, John Catalano, Robert Hills, Andrew Wei

Research output: Contribution to journalLetterResearchpeer-review

Original languageEnglish
Pages (from-to)493-496
Number of pages4
JournalLeukemia and Lymphoma
Volume59
Issue number2
DOIs
Publication statusPublished - 2018

Cite this

Tiong, Ing Soo ; Tan, Peter ; McManus, Julie ; Cummings, Nik ; Sadawarte, Sonali ; Catalano, John ; Hills, Robert ; Wei, Andrew. / Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia. In: Leukemia and Lymphoma. 2018 ; Vol. 59, No. 2. pp. 493-496.
@article{b59c8ab51ad2495ab69c39268a35aba4,
title = "Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia",
author = "Tiong, {Ing Soo} and Peter Tan and Julie McManus and Nik Cummings and Sonali Sadawarte and John Catalano and Robert Hills and Andrew Wei",
year = "2018",
doi = "10.1080/10428194.2017.1334122",
language = "English",
volume = "59",
pages = "493--496",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor & Francis",
number = "2",

}

Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia. / Tiong, Ing Soo; Tan, Peter; McManus, Julie; Cummings, Nik; Sadawarte, Sonali; Catalano, John; Hills, Robert; Wei, Andrew.

In: Leukemia and Lymphoma, Vol. 59, No. 2, 2018, p. 493-496.

Research output: Contribution to journalLetterResearchpeer-review

TY - JOUR

T1 - Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia

AU - Tiong, Ing Soo

AU - Tan, Peter

AU - McManus, Julie

AU - Cummings, Nik

AU - Sadawarte, Sonali

AU - Catalano, John

AU - Hills, Robert

AU - Wei, Andrew

PY - 2018

Y1 - 2018

UR - http://www.scopus.com/inward/record.url?scp=85020444787&partnerID=8YFLogxK

U2 - 10.1080/10428194.2017.1334122

DO - 10.1080/10428194.2017.1334122

M3 - Letter

VL - 59

SP - 493

EP - 496

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 2

ER -